Synonyms:001, RAD, 40-O-(2-hydroxyethyl)-rapamycin, 40-O-(2-Hydroxyethyl)rapamycin, Afinitor, Certican, Everolimus, RAD, RAD 001, RAD, SDZ, RAD001, SDZ RAD, SDZ-RAD, Zortress, 159351-69-6, 42-O-(2-Hydroxyethyl)rapamycin, Votubia, Afinitor Disperz, CHEBI:68478, RAD-001, Rapamycin, 42-O-(2-hydroxyethyl)-, UNII-9HW64Q8G6G, 9HW64Q8G6G, NCGC00167512-01, Everolimus (RAD001), (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-12-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone, everolimusum, NSC733504, Everolimus solution, Everolimus (INN), SDZRAD, XIENCE V, Everolimus - RAD001, SCHEMBL4378, DSSTox_CID_20599, DSSTox_RID_79508, NVP-RAD001, DSSTox_GSID_40599, Everolimus [USAN:INN:BAN], NVP-RAD-001, Everolimus, analytical standard, GTPL5889, RAD-001C, CHEMBL1908360, DTXSID0040599, HSDB 8255, RAD 666, RAD-666, Everolimus; RAD001; SDZ-RAD, C53H83NO14, 42-O-(2-Hydroxyethyl)-rapamycin, EX-A2057, Tox21_112510, BDBM50088378, AKOS015850977, ZINC169677008, CS-0064, DB01590, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone, (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone, (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, AS-16971, AT-22180, HY-10218, CAS-159351-69-6, V2036, Everolimus solution, 1.0 mg/ml in acetonitrile, 351E696, Q421052, Q-101413, BRD-K13514097-001-01-2, BRD-K13514097-001-05-3, dihydroxy-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl]-dimethoxy-hexamethyl-[?]pentone, Everolimus solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material
Pubchem:PUBCHEM:6442177
Id:6442177
Description:nan
